IDEAS home Printed from https://ideas.repec.org/a/spr/pharmo/v3y2019i2d10.1007_s41669-018-0093-0.html
   My bibliography  Save this article

High Healthcare Resource Use in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids’ Inpatient Database (KID)

Author

Listed:
  • Jessica Cardenas

    (AveXis, Inc)

  • Melissa Menier

    (AveXis, Inc)

  • Marjet D. Heitzer

    (AveXis, Inc)

  • Douglas M. Sproule

    (AveXis, Inc)

Abstract

Background Patients with spinal muscular atrophy (SMA) have high healthcare resource use (HRU) due to respiratory and nutritional complications resulting from progressive muscle atrophy. While previous studies estimate the direct costs to be US$113,000 to US$121,682 per year in the US, they potentially understate costs for type 1 SMA (SMA1). This study analyzed HRU in hospitalizations with a diagnosis of SMA1 and compared it with hospitalizations with complex chronic conditions (CCC) other than SMA1 or those with no CCC. Methods This retrospective analysis of a defined subset of the 2012 Kids’ Inpatient Database (KID) compared a nationally estimated number of hospitalizations of children (aged

Suggested Citation

  • Jessica Cardenas & Melissa Menier & Marjet D. Heitzer & Douglas M. Sproule, 2019. "High Healthcare Resource Use in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids’ Inpatient Database (KID)," PharmacoEconomics - Open, Springer, vol. 3(2), pages 205-213, June.
    • Handle: RePEc:spr:pharmo:v:3:y:2019:i:2:d:10.1007_s41669-018-0093-0
    DOI: 10.1007/s41669-018-0093-0
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s41669-018-0093-0
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1007/s41669-018-0093-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharmo:v:3:y:2019:i:2:d:10.1007_s41669-018-0093-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.